{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:29:07Z","timestamp":1790094547457,"version":"4.0.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,21]]},"DOI":"10.7759\/cureus.90700","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T04:47:20Z","timestamp":1755838040000},"source":"Crossref","is-referenced-by-count":1,"title":["Generalized Rash and Angioedema During Triple Antiepileptic Therapy: A Case Report"],"prefix":"10.7759","author":[{"given":"Zlatana K","family":"Perovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slavica","family":"Vujisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2019.07.015","article-title":"Rashes and other hypersensitivity reactions associated with antiepileptic drugs: a review of current literature","volume":"71","author":"Mani R","year":"2019","unstructured":"Mani R, Monteleone C, Schalock PC, Truong T, Zhang XB, Wagner ML. Rashes and other hypersensitivity reactions associated with antiepileptic drugs: a review of current literature. Seizure. 2019, 71:270-8. 10.1016\/j.seizure.2019.07.015","journal-title":"Seizure"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2015.11.017","article-title":"Adverse drug reactions and organ damage: the skin","volume":"28","author":"Marzano AV","year":"2016","unstructured":"Marzano AV, Borghi A, Cugno M. Adverse drug reactions and organ damage: the skin. Eur J Intern Med. 2016, 28:17-24. 10.1016\/j.ejim.2015.11.017","journal-title":"Eur J Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2019.07.003","article-title":"Risks and management of antiepileptic drug induced skin reactions in the adult out-patient setting","volume":"72","author":"Fowler T","year":"2019","unstructured":"Fowler T, Bansal AS, Lozs\u00e1di D. Risks and management of antiepileptic drug induced skin reactions in the adult out-patient setting. Seizure. 2019, 72:61-70. 10.1016\/j.seizure.2019.07.003","journal-title":"Seizure"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2020.01.002","article-title":"Levetiracetam and cutaneous adverse reactions: a systematic review of descriptive studies","volume":"75","author":"Rashid M","year":"2020","unstructured":"Rashid M, Rajan AK, Chhabra M, Kashyap A. Levetiracetam and cutaneous adverse reactions: a systematic review of descriptive studies. Seizure. 2020, 75:101-9. 10.1016\/j.seizure.2020.01.002","journal-title":"Seizure"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2012.03.007","article-title":"Levetiracetam induced angioedema in a patient with previous anticonvulsant hypersensitivity reaction to phenytoin and lamotrigine","volume":"21","author":"Alkhotani A","year":"2012","unstructured":"Alkhotani A, McLachlan RS. Levetiracetam induced angioedema in a patient with previous anticonvulsant hypersensitivity reaction to phenytoin and lamotrigine. Seizure. 2012, 21:407-8. 10.1016\/j.seizure.2012.03.007","journal-title":"Seizure"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2014.11.009","article-title":"Antiepileptic drugs and adverse skin reactions: an update","volume":"67","author":"B\u0142aszczyk B","year":"2015","unstructured":"B\u0142aszczyk B, Laso\u0144 W, Czuczwar SJ. Antiepileptic drugs and adverse skin reactions: an update. Pharmacol Rep. 2015, 67:426-34. 10.1016\/j.pharep.2014.11.009","journal-title":"Pharmacol Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40199-023-00488-6","article-title":"Immediate hypersensitivity reaction to levetiracetam: a case report study","volume":"32","author":"Hosseini MS","year":"2024","unstructured":"Hosseini MS, Namazi S. Immediate hypersensitivity reaction to levetiracetam: a case report study. Daru. 2024, 32:435-8. 10.1007\/s40199-023-00488-6","journal-title":"Daru"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2013.11.005","article-title":"Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy","volume":"2","author":"Pavlos R","year":"2014","unstructured":"Pavlos R, Mallal S, Ostrov D, Pompeu Y, Phillips E. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy. J Allergy Clin Immunol Pract. 2014, 2:21-33. 10.1016\/j.jaip.2013.11.005","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis","volume":"10","author":"Hama N","year":"2022","unstructured":"Hama N, Abe R, Gibson A, Phillips EJ. Drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis. J Allergy Clin Immunol Pract. 2022, 10:1155-67.e5. 10.1016\/j.jaip.2022.02.004","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2010.03764.x","article-title":"Delayed drug hypersensitivity: models of T-cell stimulation","volume":"71","author":"Adam J","year":"2011","unstructured":"Adam J, Pichler WJ, Yerly D. Delayed drug hypersensitivity: models of T-cell stimulation. Br J Clin Pharmacol. 2011, 71:701-7. 10.1111\/j.1365-2125.2010.03764.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2016.02.014","article-title":"Skin rash following levetiracetam","volume":"37","author":"Bhoi SK","year":"2016","unstructured":"Bhoi SK, Kalita J, Misra UK. Skin rash following levetiracetam. Seizure. 2016, 37:45-7. 10.1016\/j.seizure.2016.02.014","journal-title":"Seizure"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2024.03.009","article-title":"Real-world safety of levetiracetam: mining and analysis of its adverse drug reactions based on FAERS database","volume":"117","author":"He Z","year":"2024","unstructured":"He Z, Liu C, Lin L, Feng G, Wu G. Real-world safety of levetiracetam: mining and analysis of its adverse drug reactions based on FAERS database. Seizure. 2024, 117:253-60. 10.1016\/j.seizure.2024.03.009","journal-title":"Seizure"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2000.00467.x","article-title":"Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro","volume":"55","author":"Schaub N","year":"2000","unstructured":"Schaub N, Bircher AJ. Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro. Allergy. 2000, 55:191-3. 10.1034\/j.1398-9995.2000.00467.x","journal-title":"Allergy"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14591","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: an analysis of the US Food and Drug Administration Adverse Event Reporting System","volume":"59","author":"Borrelli EP","year":"2018","unstructured":"Borrelli EP, Lee EY, Descoteaux AM, Kogut SJ, Caffrey AR. Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: an analysis of the US Food and Drug Administration Adverse Event Reporting System. Epilepsia. 2018, 59:2318-24. 10.1111\/epi.14591","journal-title":"Epilepsia"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/all.12161","article-title":"Desensitization in delayed drug hypersensitivity reactions -- an EAACI position paper of the Drug Allergy Interest Group","volume":"68","author":"Scherer K","year":"2013","unstructured":"Scherer K, Brockow K, Aberer W, et al.. Desensitization in delayed drug hypersensitivity reactions -- an EAACI position paper of the Drug Allergy Interest Group. Allergy. 2013, 68:844-52. 10.1111\/all.12161","journal-title":"Allergy"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/394698-generalized-rash-and-angioedema-during-triple-antiepileptic-therapy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T04:47:23Z","timestamp":1755838043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/394698-generalized-rash-and-angioedema-during-triple-antiepileptic-therapy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.90700","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,21]]}}}